Literature DB >> 7506206

Progestin-induced growth hormone excess in the dog originates in the mammary gland.

P J Selman1, J A Mol, G R Rutteman, E van Garderen, A Rijnberk.   

Abstract

In the dog endogenous progesterone and synthetic progestins may incite overproduction of GH, resulting in acromegaly and insulin resistance. This progrestin-induced excessive GH secretion is characterized by disappearance of the pulsatile secretion pattern and insensitivity to both stimulation with GHRH and inhibition with a somatostatin analog. This progestin-induced GH hypersecretion is not associated with neoplastic transformation at the pituitary level. These observations were the impetus for a search of a possible extrapituitary site of GH production. In four ovariohysterectomized dogs elevated plasma GH levels (46.5 +/- 7.7 micrograms/liter; mean +/- SEM) were induced by administration of synthetic progestins. In these dogs hypophysectomy did not led to a significant decrease in plasma GH levels. Analysis of the GH content of various tissue homogenates revealed that the highest GH immunoreactivity was found in extracts of the mammary gland. Ectopic production of GH in the mammary gland was confirmed by lowering of plasma GH concentration to values within the reference range within 2 h after complete mammectomy in two dogs with progestin-induced elevations of plasma GH levels. In one of these dogs the arterial and elevations of plasma GH levels. In one of these dogs the arterial and venous GH concentrations across the mammary gland were measured and an arterio-venous GH gradient was demonstrated. Displacement studies in the RIA and analysis by reversed-phase HPLC revealed that mammary-derived GH is highly similar to pituitary-derived GH. Immuno-histochemical staining revealed that GH immunoreactivity was localized in focal areas of hyperplastic ductular epithelium. In mammary tissue of healthy untreated female dogs no GH immunoreactivity was found. It is concluded that treatment of dogs with synthetic progestins can induce the overproduction of GH in the mammary gland. This GH is biologically active, highly similar to pituitary derived GH, and originates from foci of hyperplastic ductular epithelium of the mammary gland.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506206     DOI: 10.1210/endo.134.1.7506206

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

Review 1.  Animal models for the study of milk secretion.

Authors:  C J Wilde; W L Hurley
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

Review 2.  Extrapituitary production of anterior pituitary hormones: an overview.

Authors:  S Harvey; C Arámburo; E J Sanders
Journal:  Endocrine       Date:  2011-11-15       Impact factor: 3.633

Review 3.  Canine diabetes mellitus: can old dogs teach us new tricks?

Authors:  B Catchpole; J M Ristic; L M Fleeman; L J Davison
Journal:  Diabetologia       Date:  2005-09-08       Impact factor: 10.122

Review 4.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 5.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

6.  Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Authors:  Francesco Zublena; Alice Tamborini; Carmel T Mooney; Susan M North; Monika A Lobacz; Dan Andrew; Vanessa Woolhead; Heather Covey; Herbert A Schmid; David B Church; Stijn J M Niessen
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

7.  Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop.

Authors:  E van Garderen; M de Wit; W F Voorhout; G R Rutteman; J A Mol; H Nederbragt; W Misdorp
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

8.  Expression of the growth hormone gene in immune tissues.

Authors:  C L Render; K L Hull; S Harvey
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

Review 9.  Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival.

Authors:  D J Flint; C H Knight
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 10.  Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Authors:  Heidi N Hilton; J Dinny Graham; Christine L Clarke
Journal:  Mol Endocrinol       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.